Acute promyelocytic leukemia (APL) is a type of acute myeloid leukemia. Healthcare providers may call it APL leukemia or M3-leukemia. It’s a type of blood cancer that can be life-threatening. It may cause serious bleeding issues, severe anemia and infections. Treatment can cure most cases of APL, but it can come back.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Acute promyelocytic leukemia (APL) is a rare blood cancer. It’s a form of acute myeloid leukemia that happens when a genetic mutation (change) creates abnormal white blood cells that multiply uncontrollably in your bone marrow. Healthcare providers may call this condition APL leukemia or M3-leukemia.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
APL is a serious condition with life-threatening symptoms, including excessive bleeding, which come on suddenly and quickly get worse. Thanks to treatment that’s an innovative combination of chemotherapy and non-chemotherapy drugs, healthcare providers can treat and often cure acute promyelocytic leukemia.
APL is rare, affecting 30,000 people in the U.S. each year. Most people are in their 30s when they receive an APL diagnosis.
Acute promyelocytic leukemia (APL) symptoms develop when your bone marrow can’t make normal numbers of red blood cells, white blood cells and platelets. If you have low blood cell levels (pancytopenia), you may develop serious symptoms, including anemia, bleeding issues (hemorrhage) and infections.
Other APL symptoms are:
In acute promyelocytic leukemia, you don’t have enough platelets or blood clotting factors. Platelets slow or stop bleeding. Blood clotting factors help make clots in your blood. APL bleeding symptoms include:
Advertisement
This condition happens when two genes that drive blood cell development fuse to create the abnormal gene PML-RARa. You don’t inherit this genetic mutation (change). It happens randomly during your lifetime. Experts don’t know what triggers the change.
The mutation keeps white blood cells from developing as they should. The immature white blood cells (promyelocytes) multiply uncontrollably, crowding out healthy blood cells and platelets.
APL can be life-threatening, causing severe bleeding that quickly gets worse. Contact a healthcare provider or go to the emergency department if you have bleeding that you can’t control, like bleeding from a cut or injury or there’s lots of blood in the toilet after you poop or pee or bleeding gums.
Healthcare providers typically order the following tests to diagnose this condition:
Healthcare providers use white blood cell counts to classify cases as being low- or high-risk APL. People with high-risk acute promyelocytic leukemia are more likely to experience relapse (recurrent cancer).
APL treatment is a combination of differentiation agents, chemotherapy and targeted therapy. This treatment combination, developed in the 1980s, transformed the condition from a fatal illness to a curable one.
Differentiation agents are non-chemotherapy treatments that help abnormal white blood cells mature (differentiate) into normal white blood cells. The non-chemotherapy treatment described below has increased the remission and cure rate to more than 95%.
Advertisement
Differentiation agents for APL are:
If your healthcare provider suspects you have APL, they’ll likely prescribe ATRA right away, even before tests confirm you have APL. Prompt treatment reduces the risk of life-threatening bleeding.
Treatment includes three phases: induction, consolidation and maintenance. Treatments vary, depending on risk:
Advertisement
Your oncologist may combine treatment with supportive therapy like blood transfusions.
The most common and serious complication is differentiation syndrome. This is a group of severe reactions to APL drugs. The reactions typically develop during the first three weeks of induction or initial treatment. Symptoms may be mild or severe and include:
If you experience differentiation syndrome, your provider might stop treatment. They may use other drugs like hydroxyurea to bring down your white blood cell levels.
In general, the prognosis is good. While everyone’s situation is different, studies show between 90% and 95% of APL cases go into remission. APL can come back (recur) after treatment. Between 5% to 10% of people experience relapse, usually within the first three years after treatment, and need more or different treatment.
Acute promyelocytic leukemia is a rare disease, so what we know about survival rates comes from clinical trials involving people with low-risk and high-risk APL.
Advertisement
One analysis of clinical trials involving low-risk APL cases found that 99% of people were alive four years after treatment. Another analysis of research involving high-risk APL cases shows that 86% of people were alive after five years.
Acute promyelocytic leukemia (APL) can come back (recur), so it’s important that you make it to your follow-up appointments.
You’ll probably have a check-up every month to two months for the first year after your treatment. After the first year, you’ll probably see your provider every three to four months for the next two years. Follow-up appointments may include tests like CBCs, PCRs and bone marrow biopsy.
APL can come back after treatment, causing symptoms that can get worse very quickly. If you’re in remission from acute promyelocytic leukemia, go to the emergency room right away if you have:
Acute promyelocytic leukemia (APL) is a rare blood cancer that once was a fatal illness. Now, healthcare providers consider APL a curable disease, thanks to an innovative combination of chemotherapy and non-chemotherapy drugs.
But acute promyelocytic leukemia is still a serious illness — without prompt diagnosis and treatment, it can be life-threatening. Don’t hesitate to contact a healthcare provider anytime you have symptoms like bleeding that you can’t control so you can get help — and a diagnosis — as soon as possible.
Last reviewed on 04/02/2024.
Learn more about the Health Library and our editorial process.